CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort
, , , , , e
06 mar 2025
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: ORIGINAL ARTICLE
Pubblicato online: 06 mar 2025
Pagine: 5 - 12
DOI: https://doi.org/10.2478/bjmg-2024-0020
Parole chiave
© 2024 Krstevska Bozhinovikj E et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Krstevska Bozhinovikj, E
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in SkopjeSkopje, N. Macedonia
Matevska-Geshkovska, N
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in SkopjeSkopje, N. Macedonia
Staninova Stojovska, M
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in SkopjeSkopje, N. Macedonia
Gjorgievska, E
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in SkopjeSkopje, N. Macedonia
Jovanovska, A
University Clinic for Pediatric diseases, Faculty of Medicine, University Ss. Cyril and Methodius in SkopjeSkopje, N. Macedonia
Kocheva, S
University Clinic for Pediatric diseases, Faculty of Medicine, University Ss. Cyril and Methodius in SkopjeSkopje, N. Macedonia
Dimovski, A
Center for Biomolecular Pharmaceutical Analyses, Faculty of Pharmacy, University Ss. Cyril and Methodius in SkopjeSkopje, N. Macedonia
Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Sciences and ArtsSkopje, N. Macedonia